Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study
Seth E. Karol, Thomas Alexander, Amit Budhraja, Stanley Pounds, Kristin Canavera, Lei Wang, Joshua Wolf, Jeffery M. Klco, Paul E. Mead, Soumyasri Das Gupta, Su Y. Kim, Ahmed Hamed Salem, Tammy L. Palenski, Norman J. Lacayo, Ching‐Hon Pui, Joseph T. Opferman, Jeffrey E. Rubnitz
Topics & Concepts
IdarubicinCytarabineVenetoclaxRefractory (planetary science)MedicineMyeloid leukaemiaMyeloidOncologyInternal medicineMyeloid leukemiaLeukemiaPhysicsChronic lymphocytic leukemiaAstrobiologyAcute Myeloid Leukemia ResearchNeutropenia and Cancer InfectionsAcute Lymphoblastic Leukemia research